Skip to content
Home
About Us
Contributors
Publications
Aron 1 – Renal Cell Carcinoma
Aron 2 – Urothelial carcinoma
Aron 3 – Prostate Cancer
Aron – supplementaries
Contact Us
Menu
Home
About Us
Contributors
Publications
Aron 1 – Renal Cell Carcinoma
Aron 2 – Urothelial carcinoma
Aron 3 – Prostate Cancer
Aron – supplementaries
Contact Us
Supplementary studies
Nutritional conditions and PFS and OS in cancer immunotherapy: the MOUSEION-010 meta-analysis
Vitale E
et al. Immunotherapy
2025
Impact of time-of-day administration of immunotherapy on survival in metastatic renal cellcarcinoma: the MOUSEION-09 meta-analysis
Alessandro Rizzo
et al. Clin Exp Metastasis
2024
Metastatic sites and clinical outcomes in renal cell carcinoma patients receiving immune-based combinations: the MOUSEION-08 study
Alessandro Rizzo
et al. Clin Exp Metastasis
2024
Sex differences in adverse events among cancer patients receiving immune checkpointinhibitors: the MOUSEION-07 systematic review and meta-analysis
Elsa Vitale
Elsa Vitale et al. Sci Rep
2024
The impact of ECOG performance status on efficacy of immunotherapy and immune-basedcombinations in cancer patients: the MOUSEION-06 study
Veronica Mollica
et al. Clin Exp Med
2023
Hypertransaminasemia in cancer patients receiving immunotherapy and immune-basedcombinations: the MOUSEION-05 study
Alessandro Rizzo
et al. Cancer Immunol Immunother
2023
Previous
Page
1
Page
2
Next
